IVAX BUYING GOLDLINE GENERIC DRUG DISTRIBUTOR FOR $ 33 MIL. AND NOVEN FOR $ 47 MIL.; TWO ACQUISITIONS WILL PUT IVAX IN TRANSDERMAL PATCHES, BOOST GENERICS EFFORT

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".